Polen Capital, an investment management company, released its fourth-quarter investor letter for “Polen 5Perspectives Small Mid Growth Strategy”. The Polen 5Perspectives Small-Mid Growth Composite Portfolio returned -0.1% gross and -0.3% net of fees in the fourth quarter of 2025, compared to a 0.3% return of the Russell 2500 Growth Index. Following double-digit returns in 2Q and 3Q, SMID caps concluded the year with a 0.3% return in 4Q. Biotech stood out as a major performer during the quarter, expanding beyond the AI theme. The name of the Strategy changed from Polen U.S. SMID Cap...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.